RE: Another one bites the dust!10 Jul 2024 14:39
I think there are some clues that investors can rely on
Firstly, the first commercial order from STM was also delayed
Secondly, when the distribution of funds was announced the company explained that it wanted to keep back sufficient cash to ensure it could reach break even without another raise. This explanation told me that they were being prudent by not totally relying on another order this FY and I was not surprised by the slightly adverse trading update.
None of this is unusual. On the contrary, the normal business experience is that things never run to schedule.
The final clue is the resumption of the buyback coincident with the most recent trading statement, which tells me they're sufficiently confident of comfortably reaching break even regardless of any delays.
The precise words in the respective RNS are:-
"Following customer dialogue", which, since they have not stated the Gen 1 materials have been shelved and since the buyback resumed can only imply that they've received reassuring information from STM - at least some level that isn't sufficiently definitive to state in an RNS.
and
"The Group is working with its customer to understand the range of possible outcomes and any potential impact on Nanoco beyond the end of the financial year". This is where they try to justify the lack of clear guidance and it I interpret it to mean that they're helping STM to obtain a crisper understanding from it's customers in turn.